全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

Seroprevalence of Hepatitis B among Blood Donors in Mbuji-Mayi, “Case of Dipumba General Hospital” (DRC)

DOI: 10.4236/oalib.1103503, PP. 1-7

Subject Areas: Public Health, Hematology

Keywords: Seroprevalence, Hepatitis B, Donors, Mbuji-Mayi

Full-Text   Cite this paper   Add to My Lib

Abstract

Seroprevalence among blood donors is a major public health problem, both in developed and developing countries, in its magnitude. The aim of this study was to determine the seroprevalence of hepatitis B in blood donors. This is a descriptive study carried out in the city of Mbuji-Mayi at the General Hospital of Dipumba in blood donors (family, volunteer and remunerated) recorded from 01/to31/December 2016; the data were collected in a transverse fashion. The following observations were made: During the study period, 1584 blood donors were registered. After analyzing the data, the seroprevalence of hepatitis B in blood donors was 2.2%, 77.8% were male (sex ratio M/F 3.5 and voluntary donors were 50.4%.

Cite this paper

Paul, C. M. , Moise, K. K. , Blood, B. N. D. , Kennedy, N. M. , Réne, J. M. M. , Alain, K. K. , Brigitte, K. T. , Lubemba, G. M. , Laurent, B. L. and Michel, K. N. (2017). Seroprevalence of Hepatitis B among Blood Donors in Mbuji-Mayi, “Case of Dipumba General Hospital” (DRC). Open Access Library Journal, 4, e3503. doi: http://dx.doi.org/10.4236/oalib.1103503.

References

[1]  Heymann, D.L. (2004) Control of Communicable Diseases Manual. APHA, Washington DC, 253-261.
[2]  Tounkara, A., Sarro, Y.S., Kristensen, S., et al. (2009) Seroprevalence of HIV/HBV Co-Infection in Blood Donors Malian. Journal of the International Association of Physicians in AIDS Care, 8, 47-51.
[3]  Pillonel, J. and Laperche, S. (2001) Monitoring of Markers’ Infection with HIV, HTLV and Hepatitis B and C Chez Blood Donors in France from 1991 to 2000. Bulletin Epidémiologique Hebdomadaire, 47, 207-209.
[4]  Pillonel, J., Marrec, N., Girault, A., David, D. and Laperche, S. (2005) Epidemiological Surveillance Homologous Blood Donors in France and Residual Risk between 2001 and 2003. Transfusion Clinique et Biologique, 12, 239-246.
[5]  Manoliu, C.L., Cleril, M., Jasmin, B., Langou, T., Pincemail, P., Bolo, F. and Guilhem, I. (2015) Genetic Diversity of the Virus Hepatitis B among Blood Donors in Guadeloupe Posters/Transfusion. Clinique et Biologique, 20, 295-369.
[6]  Batina, A., Kabemba, S. and Malengela, R. (2007) Infectious Markers among Blood Donors in Democratic Republic of Congo. Revue Médicale de Bruxelles, 28, 145-149.
[7]  Koné, M.C., Sidibé, Mallé, K.K., Beye, S.A., Lurton, G., Dao, S., Diarra, M.T. and Dao, S. (2012) Seroprevalence of the Virus Human Immunodeficiency Virus and Hepatitis B and C among Blood Donors in Segou (Mali). Medicine and Tropical Health, 22, N8.
[8]  Sida, M.B., Gapdo, J., Mbangue, M., Essola, J., Leundji, H. and Dissongoii, J. (2015) Prevalence of HBC Antibodies in Blood Donors Ag Hbs Negatives to Laquintinie Hospital Doua Home. The Journal of Medicine and Health Sciences, 16.
http://www.hsd-fmsb.org/index.php/hsd/article/view/499/0 
[9]  CNTS (2005) 6th Scientific Days of Blood Transfusion. DRC, Kinshasa.
[10]  Michel, K.N. and Benjamin, I.K. (2013) Prévalence des marqueurs infectieux chez les donneurs de sang en milieu rural. Cas de l’hopital général de référence de Kamina. Santé Publique, 25, 213-217.
http://www.cairn.info/revue-sante-publique-2013-2-page-213.htm 
[11]  Namululi, B.A., Guerrieri, C. and Dramaix, M.W. (2015) Prevalence and Incidence of HIV and the Hepatitis B in Blood Donors and Estimation of the Risk of Transmission of HIV and HBV Virus through Blood Transfusion. A Study in the General Provincial Referral Hospital in Bukavu, Democratic Republic of Congo.
[12]  Kapila, N.G., Van Der Veken, W., Ruppol, S. and Mulumba, A. (2005) Contribution of Belgian Technical Cooperation in Blood Transfusion in Republic of the Congo from 2002 to 2004. TransfusClinBiol, 12, S1-S43.
[13]  Elect Dokekias, A., Okandze-Elenga, J.P., Dzia Lepfoundzou, A. and Parra, H.J. (2002) Prevalence of Major Viral Markers in Blood Donors Brazza City. Gas Transfus, 4-6.
[14]  Mbendi, N.C., Longo-Mbenza, B., Mbendi Nsukini, S., Muyembe Tamfum, J.J., Sitakipuanza Nanituma, H. and Vangu Ngoma, D. (2001) Prevalence of HIV and l HBsAg among Blood Donors. Residual Contamination in Recipients of Blood in Kinshasa-East, Democratic Republic of Congo. Tropical Medicine, 61, 139-142.
[15]  Kra, O., Dri, N., Ehui, E. and Ouattara, B. (2007) Prevalence of HBs Antigen in Blood Donors at the Regional Blood Transfusion Center in Bouaké (Cote d’Ivoire) in 2001. Bulletin de la Société de Pathologie Exotique, 100, 127-129.
[16]  Allain, J.P., Candotti, D., Soldan, K., Sarkodie, F., Phelps, B., Giachetti, C., et al. (2003) The Risk of Hepatitis B Virus Infection by Transfusion in Kumasi, Ghana. Blood, 101, 2419-2425.
[17]  Christian, N.K., Olivier, M., Kapend, S.M., et al. (2016) Epidemiological Profile and Prevalence of Blood Donors to the University Clinics in Lubumbashi, Democratic Republic of Congo. Pan African Medical Journal, 23, 175.
[18]  Rajab, J.A., Muchina, W.P., Orinda, D.A. and Scott, C.S. (2005) Blood Donor Hematology Parameters in Two Regions of Kenya. East African Medical Journal, 346, 530-536.
[19]  Nébié, K.Y., Olinger, C.M., Kafando, E., Dahourou, H., Diallo, S., Kientega, Y., Domo, Y., Kienou, K., Ouattara, S., Sawadogo, I., Ky, L. and Muller, P.O. (2007) Lack of Knowledge among Blood Donors in Burkina Faso (West Africa); Potential Obstacle to Transfusion Security. Transfusion Clinique et Biologique, 14, 446-452.
[20]  Noubiap, J.J., Joko, W.Y., Nansseu, J.R., Tene, U.G. and Siaka, C. (2013) Sero-Epidemiology of Human Immunodeficiency Virus, Hepatitis B and C Viruses, and Syphilis Infections among First-Time Blood Donors in Edea, Cameroon. International Journal of Infectious Diseases, 17, 832-837.
[21]  WHO (2016) Blood Safety and Supply of Blood.
http://www.who.int/mediacentre/factsheets/fs279/fr/
[22]  World Health Organization (2010) Screening of Infections Transmitted by Transfusion in Blood Donations. WHO, Geneva.

Full-Text


comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413